District to share in $17m pharmaceutical settlement

Published



The District is part of nationwide settlement for $17 million with KV Pharmaceutical Company on allegations that the company “failed to advise the Centers for Medicare and Medicaid Services that two unapproved products did not qualify for coverage under federal and state health care programs.”

The city’s inspector general made the announcement last month to city officials but posted the news publicly this week.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.